Pancreatic Cancer Research

ResearcherUniversity of CambridgeActive in the last 2 years

Andrés García-Sampedro

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2286-8623; OpenAlex author ID A5054077820. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Pentablock thermoresponsive hydrogels for chemotherapeutic delivery in a pancreatic cancer model. Co-author DOI 10.1039/d4bm01629g↗
  2. Smart Nanoparticles as Advanced Anti-Akt Kinase Delivery Systems for Pancreatic Cancer Therapy. First author DOI 10.1021/acsami.1c14592↗
  3. The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies. Co-author DOI 10.3390/jcm10040566↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pilar Acedo Núñez · 2 shared papers, 2021 · strength 0.32
  2. Cameron Alexander · 1 shared paper, 2025 · strength 0.22
  3. Cara Moloney · 1 shared paper, 2025 · strength 0.22
  4. Amr Elsherbeny · 1 shared paper, 2025 · strength 0.22
  5. Anna M. Grabowska · 1 shared paper, 2025 · strength 0.22
  6. Alexander Ney · 1 shared paper, 2021 · strength 0.17
  7. Juan González‐Valdivieso · 1 shared paper, 2021 · strength 0.15
  8. Stephen P. Pereira · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.